Evidence map›Paper›PMID 31613968›Full record

ArticleInflammatory bowel diseases2020

Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.

Manuel B Braga Neto, Martin H Gregory, Guilherme P Ramos, Fateh Bazerbachi, David H Bruining, Barham K Abu Dayyeh, Vladimir M Kushnir, Laura E Raffals, Matthew A Ciorba, Edward V Loftus and 1 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Inflammatory bowel diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Efficacy of tirzepatide for weight loss and it's comparative effectiveness to weight loss surgery in inflammatory bowel disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Impact of Obesity and Metabolic Syndrome on IBD Outcomes.Digestive diseases and sciences · 2024
    Review
  13. Article
  14. Obesity and novel management of inflammatory bowel disease.World journal of gastroenterology · 2023
    Review
  15. Article
  16. Impact of Obesity on Inflammatory Bowel Disease.Current gastroenterology reports · 2022
    Review
  17. Visceral adiposity and inflammatory bowel disease.International journal of colorectal disease · 2021
    Review
  18. Review
  19. Article
  20. Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Manuel B Braga NetoDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Martin H GregoryDivision of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Guilherme P RamosDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Fateh BazerbachiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
David H BruiningDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Barham K Abu DayyehDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Vladimir M KushnirDivision of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Laura E RaffalsDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Matthew A CiorbaDivision of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Edward V LoftusDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Parakkal DeepakDivision of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Mayo Clinic · USWashington University in St. Louis · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGYT32DK007130 · NIDDK · WASHINGTON UNIVERSITY · PI MATTHEW AARON CIORBA · 1986 to 2026
$8.3M
NIDDK NIH HHS P30 DK052574NIDDK NIH HHS T32 DK007130
6 · The paper itself

Abstract

backgroundAn association between inflammatory bowel disease (IBD) and obesity has been observed. Little is known about the effect of weight loss on IBD course. Our aim was to determine the impact of bariatric surgery on long-term clinical course of obese patients with IBD, either Crohn's disease (CD) or ulcerative colitis (UC).

methodsPatients with IBD who underwent bariatric surgery subsequent to IBD diagnosis were identified from 2 tertiary IBD centers. Complications after bariatric surgery were recorded. Patients were matched 1:1 for age, sex, IBD subtype, phenotype, and location to patients with IBD who did not undergo bariatric surgery. Controls started follow-up at a time point in their disease similar to the disease duration in the matched case at the time of bariatric surgery. Inflammatory bowel disease medication usage and disease-related complications (need for corticosteroids, hospitalizations, and surgeries) among cases and controls were compared.

resultsForty-seven patients met inclusion criteria. Appropriate matches were found for 25 cases. Median follow-up among cases (after bariatric surgery) and controls was 7.69 and 7.89 years, respectively. Median decrease in body mass index after bariatric surgery was 12.2. Rescue corticosteroid usage and IBD-related surgeries were numerically less common in cases than controls (24% vs 52%; odds ratio [OR], 0.36; 95% confidence interval [CI], 0.08-1.23; 12% vs 28%; OR, 0.2; 95% CI, 0.004-1.79). Two cases and 1 control were able to discontinue biologics during follow-up.

conclusionsInflammatory bowel disease patients with weight loss after bariatric surgery had fewer IBD-related complications compared with matched controls. This observation requires validation in a prospective study design.

Indexed as

Bariatric SurgeryAdultColitis, UlcerativeCrohn DiseaseDisease ProgressionFemaleHumansInflammatory Bowel DiseasesMaleMiddle AgedObesityPostoperative PeriodRetrospective StudiesTreatment OutcomeWeight LossBariatric surgeryCrohn's diseaseobesityulcerative colitis

Identifiers

PMID31613968
PMCPMC7534455
OpenAlexW2980734620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.